Burcon Achieves First Commercial Run of Canola Protein Isolate
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has successfully completed its first commercial production of high-purity canola protein isolate at a partner manufacturer's facility. This achievement marks a significant milestone in the commercialization of Burcon's canola protein technology. The company has launched its Puratein® C canola protein isolate, which offers exceptional taste, nutrition, and functionality for food and beverage applications.
Key features of Puratein® C include:
- Over 90% protein purity
- Nutritionally complete amino acid profile
- Protein digestibility amino acid score (PDCAAS) of 1
- Neutral flavor
- High solubility across a broad pH range
- Superior foaming properties
Burcon plans to optimize its canola process, ramp up production, and fulfill customer orders in the coming months. The company has accelerated its launch and production timeline by six months due to significant customer interest.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) ha completato con successo la sua prima produzione commerciale di isolato proteico di canola ad alta purezza presso un impianto di un partner produttivo. Questo risultato rappresenta una tappa importante nella commercializzazione della tecnologia proteica di canola di Burcon. L'azienda ha lanciato il suo isolato proteico Puratein® C, che offre un eccezionale gusto, valore nutrizionale e funzionalità per applicazioni alimentari e delle bevande.
Le caratteristiche principali di Puratein® C includono:
- Oltre il 90% di purezza proteica
- Profilo di aminoacidi nutrizionalmente completo
- Punteggio di digeribilità proteica degli aminoacidi (PDCAAS) di 1
- Gusto neutro
- Alta solubilità in un ampio intervallo di pH
- Superiore capacità di schiumatura
Burcon prevede di ottimizzare il suo processo di canola, aumentare la produzione e soddisfare gli ordini dei clienti nei prossimi mesi. L'azienda ha accelerato il suo lancio e il programma di produzione di sei mesi a causa di un notevole interesse da parte dei clienti.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) ha completado con éxito su primera producción comercial de aislado de proteína de canola de alta pureza en una instalación de un socio fabricante. Este logro marca un hito significativo en la comercialización de la tecnología de proteína de canola de Burcon. La compañía ha lanzado su aislado de proteína de canola Puratein® C, que ofrece un sabor excepcional, nutrición y funcionalidad para aplicaciones en alimentos y bebidas.
Las características clave de Puratein® C incluyen:
- Más del 90% de pureza proteica
- Perfil de aminoácidos nutricionalmente completo
- Puntuación de digestibilidad de aminoácidos de proteína (PDCAAS) de 1
- Sabor neutro
- Alta solubilidad en un amplio rango de pH
- Propiedades de espumado superiores
Burcon planea optimizar su proceso de canola, aumentar la producción y cumplir con los pedidos de los clientes en los próximos meses. La compañía ha acelerado su lanzamiento y la línea de tiempo de producción en seis meses debido al interés significativo de los clientes.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF)가 파트너 제조업체의 시설에서 고순도 카놀라 단백질 분리체의 첫 상업적 생산을 성공적으로 완료했습니다. 이 성과는 Burcon의 카놀라 단백질 기술 상용화에 있어 중요한 이정표를 의미합니다. 이 회사는 Puratein® C 카놀라 단백질 분리체를 출시했으며, 이는 식품 및 음료 애플리케이션을 위한 뛰어난 맛, 영양 및 기능성을 제공합니다.
Puratein® C의 주요 특징은 다음과 같습니다:
- 90% 이상의 단백질 순도
- 영양적으로 완전한 아미노산 프로필
- 단백질 소화가능도 아미노산 점수(PDCAAS) 1
- 중립적인 맛
- 넓은 pH 범위에서의 높은 용해도
- 탁월한 발포 특성
Burcon은 카놀라 공정을 최적화하고 생산을 늘리며 향후 몇 달 내에 고객 주문을 이행할 계획입니다. 이 회사는 고객의 상당한 관심으로 인해 출시 및 생산 일정을 6개월 앞당겼습니다.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) a réussi à compléter sa première production commerciale d'isolat de protéine de canola de haute pureté dans l'établissement d'un partenaire fabricant. Cet accomplissement marque une étape significative dans la commercialisation de la technologie de protéine de canola de Burcon. L'entreprise a lancé son isolat de protéine de canola Puratein® C, qui offre un goût exceptionnel, une valeur nutritionnelle et une fonctionnalité pour les applications alimentaires et des boissons.
Les caractéristiques clés de Puratein® C comprennent :
- Plus de 90 % de pureté protéique
- Profil d’acides aminés nutritionnellement complet
- Score de digestibilité des acides aminés de protéine (PDCAAS) de 1
- Goût neutre
- Haute solubilité sur une large plage de pH
- Propriétés de mousse supérieures
Burcon prévoit d'optimiser son processus de canola, d'augmenter la production et de satisfaire les commandes des clients dans les mois à venir. L'entreprise a accéléré son calendrier de lancement et de production de six mois en raison d'un intérêt client significatif.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) hat erfolgreich seine erste kommerzielle Produktion von hochreinem Canola-Proteinisolat in der Einrichtung eines Partnerherstellers abgeschlossen. Dieser Erfolg stellt einen bedeutenden Meilenstein in der Kommerzialisierung von Burcons Canola-Protein-Technologie dar. Das Unternehmen hat sein Puratein® C Canola-Proteinisolat eingeführt, das außergewöhnlichen Geschmack, Nährwert und Funktionalität für Lebensmittel- und Geträneanwendungen bietet.
Wesentliche Merkmale von Puratein® C sind:
- Über 90 % Proteinreinheit
- Ernährungsphysiologisch vollständiges Aminosäureprofil
- Proteinverdaulichkeits-Aminosäurescore (PDCAAS) von 1
- Neutrale Geschmacksnote
- Hohe Löslichkeit über einen breiten pH-Bereich
- Überlegene Schäumungseigenschaften
Burcon plant, seinen Canola-Prozess zu optimieren, die Produktion zu steigern und in den kommenden Monaten Kundenbestellungen zu erfüllen. Das Unternehmen hat seinen Produktions- und Markteinführungszeitplan um sechs Monate beschleunigt, da das Interesse der Kunden erheblich gestiegen ist.
- Successful completion of first commercial production of canola protein isolate
- Launch of Puratein® C canola protein isolate with superior nutritional and functional properties
- Accelerated production timeline by six months due to high customer interest
- Implementation of capital-light strategy for commercialization
- None.
Vancouver, British Columbia--(Newsfile Corp. - July 29, 2024) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce the successful completion of its first end-to-end validation trial for producing high-purity, nutritionally complete canola protein isolate at its partner manufacturer's facility.
Burcon has achieved a significant milestone in the commercialization of its canola protein technology. Executing its capital-light strategy, the Company successfully launched and commercially produced its best-in-class canola protein to meet the growing demand for this unique ingredient. Burcon expects to optimize its canola process, ramp up production and fulfill customer orders in the coming months.
"Due to significant customer interest in our canola protein, we decided to move up our launch and production timeline by six months," said Kip Underwood, Burcon's chief executive officer. "This one-of-a-kind protein ingredient offers functional and nutritional properties that can enhance food formulations. We are excited to bring our canola protein to market and look forward to collaborating with prospective customers."
Burcon's Puratein® C canola protein isolate delivers an exceptional combination of taste, nutrition and functionality for food and beverage applications. Extracted from non-GMO, Canadian-grown canola seeds, it boasts a nutritionally complete amino acid profile, containing all nine essential amino acids and a protein digestibility amino acid score (PDCAAS) of 1. With over
Learn more about our latest high-purity canola protein isolate at Burcon's website here. Prospective customers seeking product samples and information are encouraged to contact us at sales@burcon.ca.
About Burcon NutraScience Corporation
Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is committed to delivering next-generation, best-in-class protein solutions, positioning itself as a key player in the rapidly expanding plant-based market. Supporting the growing trend towards a plant-based diet, Burcon offers sustainable protein ingredients that we believe are better for you and better for the planet. For more information, visit www.burcon.ca.
Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-Looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-Looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2024 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca www.burcon.ca
Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/218083
FAQ
What is the significance of Burcon's first commercial run of canola protein isolate?
What are the key features of Burcon's Puratein® C canola protein isolate?
How has Burcon (BRCNF) adjusted its production timeline for canola protein?
What is Burcon's strategy for commercializing its canola protein technology?
